https://www.indianpharmapost.com/jubilant-pharmova-posts-robust-q3-eyes-vision-2030-with-sterile-injectables-drive-190662026-02-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/hcg-reports-robust-q3-9m-fy26-growth-strengthening-its-lead-in-indian-oncology-190672026-02-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/sai-life-sciences-posts-stellar-q3-revenue-surges-27-yoy-pat-nearly-doubles-190682026-02-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/dksh-malaysia-teams-up-with-pfizer-to-boost-access-to-anti-infective-therapies-190692026-02-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/mirum-pharmaceuticals-bags-canadian-nod-for-livmarli-to-treat-rare-liver-disorder-190702026-02-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/biomica-seals-exclusive-global-license-for-groundbreaking-microbiome-cancer-therapy-190712026-02-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/wanbury-reports-explosive-q3-profit-surge-signals-strong-growth-ahead-190722026-02-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/kims-hospitals-crosses-rs-1000-crore-quarterly-revenue-milestone-190732026-02-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/mhra-warns-of-extremely-rare-vision-risk-linked-to-semaglutide-190742026-02-09T00:00:00+05:30always0.9